Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroma × Botulinum Toxins, Type A × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5 Neoplasms 3 Prostatic Neoplasms 2 Pain, Postoperative 2 Pain 2 Breast Diseases 2 Wounds and Injuries 1 Stroke 1 Stomach Neoplasms 1 Spinal Cord Injuries 1 Skin Diseases 1 Rectal Neoplasms 1 Prostatic Hyperplasia 1 Pancreatic Neoplasms 1 Neuroma 1 Neoplasms by Site 1 Muscular Atrophy 1 Muscle Spasticity 1 Lower Urinary Tract Symptoms 1 Low Anterior Resection Syndrome 1 Hereditary leiomyomatosis and renal cell cancer 1 Head and Neck Neoplasms 1 Gastroparesis 1 Ganglion Cysts 1 Esophageal Neoplasms 1 Esophageal Motility Disorders 1 Esophageal Diseases 1 Esophageal Achalasia 1 Cluster Headache 1 Chronic Pain 1

Interventions

Bupivacaine 2 Therapeutics 1 Sodium Chloride 1 Ralfinamide 1 Radiofrequency Ablation 1 Musculoskeletal Manipulations 1 Methylprednisolone 1 Lidoderm 1 Lidocaine 1 Indocyanine Green 1 Dry Needling 1 Decompression 1 Cryosurgery 1 Cholecalciferol 1 Botulinum Toxins, Type A 1 Bevacizumab 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01374191 2015-08-26

Botulinum Toxin Type A for Neuroma Pain

Southern Illinois University

Phase 2 Withdrawn

Neuroma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡